secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0000950170-25-073967
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus Pharma shareholders elect directors, ratify auditor, approve say-on-pay; Rachelle Jacques appointed Board Chair
--------------------------------------------------------------------------------

- All seven director nominees elected (Yuval Cohen, Alan Holmer, Rachelle Jacques, John Jenkins, Anne Altmeyer, Yong Ben, Winston Kung; broker non-votes 2,281,655).
- Ratification of EisnerAmper LLP as independent auditor for FY2025 approved: 8,841,947 for, 154,305 against, 32,193 abstain.
- Advisory vote on named executive officer compensation passed: 6,519,904 for, 215,784 against, 11,102 abstain, 2,281,655 broker non-votes.
- Board appoints Rachelle Jacques as Chair, effective immediately, succeeding Alan Holmer who remains on board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017025073967/0000950170-25-073967-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017025073967/crbp-20250515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-073967

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer